help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-1725
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
91/4/1438    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wittrup, H. H.
Right arrow Articles by Nordestgaard, B. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wittrup, H. H.
Right arrow Articles by Nordestgaard, B. G.
Related Collections
Right arrow Lipid
Right arrow Cardiovascular Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 4 1438-1445
Copyright © 2006 by The Endocrine Society

Combined Analysis of Six Lipoprotein Lipase Genetic Variants on Triglycerides, High-Density Lipoprotein, and Ischemic Heart Disease: Cross-Sectional, Prospective, and Case-Control Studies from the Copenhagen City Heart Study

Hans H. Wittrup1, Rolf V. Andersen1, Anne Tybjærg-Hansen, Gorm B. Jensen and Børge G. Nordestgaard

Department of Clinical Biochemistry, Herlev University Hospital (H.H.W., R.V.A., B.G.N.), DK-2730 Herlev, Denmark; Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital (A.T.-H.), DK-2100 Copenhagen, Denmark; and Copenhagen City Heart Study, Bispebjerg University Hospital (A.T.-H., G.B.J., B.G.N.), DK-2400 Copenhagen, Denmark

Address all correspondence and requests for reprints to: Dr. Børge G. Nordestgaard, Department of Clinical Biochemistry, Herlev University Hospital, Herlev Ringvej 75, DK-2730 Herlev, Denmark. E-mail: brno{at}herlevhosp.kbhamt.dk.

Context: Genetic variants in lipoprotein lipase may affect triglycerides, high-density lipoprotein (HDL), and risk of ischemic heart disease (IHD).

Objective: The objective of this study was to investigate the influence of T(–93)G, G(–53)C, Asp9Asn, Gly188Glu, Asn291Ser, and Ser447Ter lipoprotein lipase genotypes on triglycerides, HDL, and IHD.

Design: The cross-sectional study involved 9004 adults. The prospective study consisted of 8817 adults developing 1001 IHD events over 23 yr. The case-control study involved 7818 non-IHD individuals vs. cohorts of 915 and 1062 IHD patients, respectively.

Setting: The study was performed in the Danish general population (the Copenhagen City Heart Study).

Participants: IHD was angina pectoris or myocardial infarction.

Main Outcome Measures: Triglycerides, HDL, and IHD were the main outcome measures.

Results: Cross-sectionally, triglycerides varied by genotype with 1.27 mmol/liter in women and 1.22 mmol/liter in men. HDL cholesterol varied by genotype with 0.49 mmol/liter in women and 0.60 mmol/liter in men. Prospectively, 9Asn (with –93G) heterozygotes and homozygotes combined vs. noncarriers had a hazard ratio for IHD of 1.6 [95% confidence interval (CI), 1.2–2.3]; 291Ser and 447Ter did not change IHD risk. In the case-control study, combining the cohorts of IHD patients, 9Asn (with –93G) heterozygotes and homozygotes combined vs. noncarriers had an odds ratio for IHD of 1.5 (CI, 1.2–2.1). 291Ser and 447Ter did not change IHD risk. Stratified for apolipoprotein E genotype, the odds ratios for IHD in 9Asn (with –93G) heterozygotes and homozygotes combined vs. noncarriers were 2.6 (CI, 1.2–5.5) among {epsilon}32 individuals and 2.4 (CI, 1.4–4.1) among {epsilon}43 individuals.

Conclusions: Genetic variation in lipoprotein lipase is associated with differences in plasma triglycerides greater than 1 mmol/liter and differences in HDL cholesterol greater than 0.5 mmol/liter. A 1.6-fold risk of IHD in 9Asn (with –93G) heterozygotes and homozygotes combined is influenced by apolipoprotein E genotype.




This article has been cited by other articles:


Home page
JAMAHome page
R. Frikke-Schmidt, B. G. Nordestgaard, M. C. A. Stene, A. A. Sethi, A. T. Remaley, P. Schnohr, P. Grande, and A. Tybjaerg-Hansen
Association of Loss-of-Function Mutations in the ABCA1 Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease
JAMA, June 4, 2008; 299(21): 2524 - 2532.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Kathiresan, O. Melander, D. Anevski, C. Guiducci, N. P. Burtt, C. Roos, J. N. Hirschhorn, G. Berglund, B. Hedblad, L. Groop, et al.
Polymorphisms Associated with Cholesterol and Risk of Cardiovascular Events
N. Engl. J. Med., March 20, 2008; 358(12): 1240 - 1249.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society